Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2025: USD 154.78 M

Hims & Hers Health, Inc. EBITDA is USD 154.78 M for the Trailing 12 Months (TTM) ending June 30, 2025, a 554.61% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 23.64 M, a -154.13% change year over year.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -43.68 M, a -51.07% change year over year.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -89.28 M, a 23.21% change year over year.
  • Hims & Hers Health, Inc. EBITDA for the Trailing 12 Months (TTM) ending June 30, 2021 was USD -72.46 M, a 90.10% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)